Search
Arcus Biosciences Inc
RCUSAdd to Watchlist
25.240USD
-0.300-1.17%
Close 09-18 16:00（ET）
3.21BMarket Cap
LossP/E TTM
After-hours 19:00 (ET)25.240USD+0.030+0.12%
After-hours 19:00 (ET)Arcus Biosciences Inc (RCUS) Revenue Performance
Updated: Jun 30, 2026Last year, Arcus Biosciences Inc generated 221.00M USD for its biggest-performing segment, License and development services revenue. The United States made the largest contribution, accounting for 382.88M USD last year.
By Business
Revenue
Proportion
Annual
Annual
Quarterly
License and development services revenue
Collaboration revenue
License revenue
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
License and development services revenue
221.00M(89.47%)
222.00M(86.05%)
80.00M(68.38%)
74.00M(66.07%)
1.14M(0.30%)
--(--)
Collaboration revenue
26.00M(10.53%)
36.00M(13.95%)
37.00M(31.62%)
38.00M(33.93%)
37.91M(9.90%)
22.42M(28.92%)
License revenue
--(--)
--(--)
--(--)
--(--)
343.84M(89.80%)
55.10M(71.08%)
By Region
Revenue
Proportion
Annual
Annual
Quarterly
United States
FY2021
United States
382.88M(100.00%)